Literature DB >> 15073597

A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas.

Zhen-Hua Lin1, Eun Mee Han, Eung Seok Lee, Chul Whan Kim, Han Kyeom Kim, Insun Kim, Young-Sik Kim.   

Abstract

KIT is expressed not only in tumors derived from hematopoietic stem cells, melanocytes, germ cells, mast cells, and interstitial cells of Cajal, but also in other malignancies such as chromophobe renal cell carcinoma. This pattern of KIT expression prompted us to investigate the expression and mutation of c-kit gene exons 9, 11, 13, 17, and intron 17 in the different subtypes of renal cell carcinomas (n=66) and non-neoplastic kidneys (n=12). We found that KIT showed strong immunoreactivity in the cytoplasm of papillary renal cell carcinomas (100%), but on the cell membranes of chromophobe renal cell carcinomas (100%). Interestingly, a specific point mutation of the c-kit intron 17 (T->A) was found only in papillary renal cell carcinomas (94%). Our study demonstrates that the expression pattern and one mutation of c-kit may distinguish papillary renal cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073597     DOI: 10.1038/modpathol.3800108

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  [Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study].

Authors:  S Waalkes; F C Roos; H Eggers; S Schumacher; M Janssen; G Wegener; J W Thüroff; R Hofmann; M Schrader; M A Kuczyk; A J Schrader
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  A renal cell carcinoma with components of both chromophobe and papillary carcinoma.

Authors:  Michael H A Roehrl; Martin K Selig; G Petur Nielsen; Paola Dal Cin; Esther Oliva
Journal:  Virchows Arch       Date:  2006-11-24       Impact factor: 4.064

3.  Similar developmental patterns in immunolocalisation of stem cell factor and KIT in bovine meso- and metanephros.

Authors:  Nikoloz Tsikolia; Michiharu Sakurai; Katharina Spanel-Borowski; Albert M Ricken
Journal:  Histochem Cell Biol       Date:  2010-02-18       Impact factor: 4.304

4.  MMP9 and SCF protect from apoptosis in acute kidney injury.

Authors:  Soraya Bengatta; Catherine Arnould; Emmanuel Letavernier; Matthieu Monge; Hélène Martinan de Préneuf; Zena Werb; Pierre Ronco; Brigitte Lelongt
Journal:  J Am Soc Nephrol       Date:  2009-04       Impact factor: 10.121

5.  Incidence and long-term prognosis of papillary renal cell carcinoma.

Authors:  A J Schrader; S Rauer-Bruening; P J Olbert; A Hegele; J Rustemeier; N Timmesfeld; Z Varga; R Hofmann
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-21       Impact factor: 4.553

6.  Tr-KIT/c-KIT ratio in renal cell carcinoma.

Authors:  Sercan Ergün; Diler Us Altay; Sezgin Güneş; Recep Büyükalpelli; Süleyman Caner Karahan; Leman Tomak; Ümmet Abur
Journal:  Mol Biol Rep       Date:  2019-07-24       Impact factor: 2.316

Review 7.  Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.

Authors:  Maryam Abbaspour Babaei; Behnam Kamalidehghan; Mohammad Saleem; Hasniza Zaman Huri; Fatemeh Ahmadipour
Journal:  Drug Des Devel Ther       Date:  2016-08-01       Impact factor: 4.162

Review 8.  Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

Authors:  Rafał Stec; Bartłomiej Grala; Michał Maczewski; Lubomir Bodnar; Cezary Szczylik
Journal:  J Exp Clin Cancer Res       Date:  2009-10-07

9.  Histological reclassification, histochemical characterization and c-kit immunoexpression in renal cell carcinoma.

Authors:  P R Rekha; S Rajendiran; Shalinee Rao; Sunil Shroff; Leena D Joseph; D Prathiba
Journal:  Indian J Urol       Date:  2008-07

10.  Immunohistochemical study of C-kit expression in subtypes of renal cell carcinoma.

Authors:  Farahnaz Norouzinia; Fariba Abbasi; Sina Dindarian; Sedra Mohammadi; Farid Meisami; Mahdi Bagheri; Hozan Mohammadi
Journal:  Turk J Urol       Date:  2018-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.